Research

Does the pain-protective GTP cyclohydrolase haplotype significantly alter the pattern or severity of pain in humans with chronic pancreatitis?

Mark Lazarev¹ , Janette Lamb¹ , M Michael Barmada² , Feng Dai³ , Michelle A Anderson⁵ , Mitchell B Max^1,3 and David C Whitcomb^1,2,4,6 for the NAPS2 Consortium

¹  Departments of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA

²  Human Genetics, University of Pittsburgh, Pittsburgh, PA 15213, USA

³  Anesthesiology, University of Pittsburgh, Pittsburgh, PA 15213, USA

⁴  Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, PA 15213, USA

⁵  Department of Medicine, University of Michigan, Ann Arbor Michigan, USA

⁶  UPMC Presbyterian, M2 C-Wing, 200 Lothrop Street, Pittsburgh, PA 15213, USA

author email corresponding author email

Molecular Pain 2008, 4:58doi:10.1186/1744-8069-4-58

Published:	17 November 2008

Abstract

Background

Pain is often a dominant clinical feature of chronic pancreatitis but the frequency and severity is highly variable between subjects. We hypothesized that genetic polymorphisms contribute to variations in clinical pain patterns. Since genetic variations in the GTP cyclohydrolase (GCH1) gene have been reported to protect some patients from pain, we investigated the effect of the "pain protective haplotype" in well characterized patients with chronic pancreatitis (CP) or recurrent acute pancreatitis (RAP) from the North American Pancreatitis Study 2 (NAPS2).

Results

Subjects in the NAPS2 study were asked to rank their pain in one of 5 categories reflecting different levels of pain frequency and severity. All subjects were genotyped at rs8007267 and rs3783641 to determine the frequency of the GCH1 pain-protective haplotype. In Caucasian subjects the frequency of the pain-protective GCH1 haplotype was no different in the control group (n = 236), CP patients (n = 265), RAP patients (N = 131), or in CP patients subclassified by pain category compared to previously reported haplotype frequencies in the general Caucasian population.

Conclusion

The GCH1 pain-protective haplotype does not have a significant effect on pain patterns or severity in RAP or CP. These results are important for helping to define the regulators of visceral pain, and to distinguish different mechanisms of pain.